This company has been marked as potentially delisted and may not be actively trading. Bioanalytical Systems (BASI) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock BASI vs. NOTV, AIKI, LUNA, ONMD, BIAF, ISPC, DKDCA, IQV, INCY, and ICLRShould you be buying Bioanalytical Systems stock or one of its competitors? The main competitors of Bioanalytical Systems include Inotiv (NOTV), AIkido Pharma (AIKI), Luna Innovations (LUNA), OneMedNet (ONMD), bioAffinity Technologies (BIAF), iSpecimen (ISPC), Data Knights Acquisition (DKDCA), IQVIA (IQV), Incyte (INCY), and ICON Public (ICLR). Bioanalytical Systems vs. Inotiv AIkido Pharma Luna Innovations OneMedNet bioAffinity Technologies iSpecimen Data Knights Acquisition IQVIA Incyte ICON Public Bioanalytical Systems (NASDAQ:BASI) and Inotiv (NASDAQ:NOTV) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their community ranking, risk, valuation, analyst recommendations, institutional ownership, media sentiment, earnings, profitability and dividends. Does the media favor BASI or NOTV? In the previous week, Bioanalytical Systems' average media sentiment score of 0.00 equaled Inotiv'saverage media sentiment score. Company Overall Sentiment Bioanalytical Systems Neutral Inotiv Neutral Does the MarketBeat Community favor BASI or NOTV? Bioanalytical Systems received 108 more outperform votes than Inotiv when rated by MarketBeat users. However, 50.00% of users gave Inotiv an outperform vote while only 35.85% of users gave Bioanalytical Systems an outperform vote. CompanyUnderperformOutperformBioanalytical SystemsOutperform Votes12835.85% Underperform Votes22964.15% InotivOutperform Votes2050.00% Underperform Votes2050.00% Which has more risk and volatility, BASI or NOTV? Bioanalytical Systems has a beta of 1.92, indicating that its share price is 92% more volatile than the S&P 500. Comparatively, Inotiv has a beta of 4.03, indicating that its share price is 303% more volatile than the S&P 500. Is BASI or NOTV more profitable? Bioanalytical Systems has a net margin of -7.75% compared to Inotiv's net margin of -25.40%. Inotiv's return on equity of -15.41% beat Bioanalytical Systems' return on equity.Company Net Margins Return on Equity Return on Assets Bioanalytical Systems-7.75% -42.74% -6.38% Inotiv -25.40%-15.41%-3.58% Do analysts recommend BASI or NOTV? Inotiv has a consensus target price of $5.00, indicating a potential upside of 147.52%. Given Inotiv's stronger consensus rating and higher possible upside, analysts plainly believe Inotiv is more favorable than Bioanalytical Systems.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bioanalytical Systems 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Inotiv 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has stronger valuation & earnings, BASI or NOTV? Bioanalytical Systems has higher earnings, but lower revenue than Inotiv. Bioanalytical Systems is trading at a lower price-to-earnings ratio than Inotiv, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBioanalytical Systems$60.47M0.37-$4.68M-$0.35-5.77Inotiv$480.40M0.14-$108.44M-$3.19-0.63 Do insiders & institutionals believe in BASI or NOTV? 10.6% of Bioanalytical Systems shares are held by institutional investors. Comparatively, 18.2% of Inotiv shares are held by institutional investors. 11.5% of Bioanalytical Systems shares are held by company insiders. Comparatively, 7.8% of Inotiv shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. SummaryInotiv beats Bioanalytical Systems on 10 of the 16 factors compared between the two stocks. Get Bioanalytical Systems News Delivered to You Automatically Sign up to receive the latest news and ratings for BASI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BASI vs. The Competition Export to ExcelMetricBioanalytical SystemsCommercial Physical Research IndustryMedical SectorNASDAQ ExchangeMarket Cap$22.49M$3.00B$5.38B$8.39BDividend YieldN/A2.27%5.21%4.10%P/E Ratio-4.81109.8026.7619.71Price / Sales0.37162.05389.94117.54Price / Cash558.4034.5738.2534.62Price / Book2.932.356.804.50Net Income-$4.68M$118.81M$3.23B$248.18M Bioanalytical Systems Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BASIBioanalytical SystemsN/A$2.02-8.2%N/A+19.6%$22.49M$60.47M-4.81397Analyst ForecastHigh Trading VolumeNOTVInotiv1.5891 of 5 stars$2.19+11.7%$6.25+185.4%-4.7%$73.84M$475.11M-0.482,100Gap UpAIKIAIkido PharmaN/A$5.99+12.6%N/A+145.8%$32.86M$10,000.00-1.544High Trading VolumeLUNALuna InnovationsN/A$0.40flatN/A-86.8%$13.58M$116.61M0.00390Analyst ForecastGap DownONMDOneMedNet0.8427 of 5 stars$0.38-6.3%N/A-20.0%$11.81M$643,000.00-1.072Positive NewsGap DownBIAFbioAffinity Technologies1.935 of 5 stars$0.20-2.9%$6.00+2,900.0%-88.1%$3.65M$9.36M-0.2410Earnings ReportGap DownISPCiSpecimen0.294 of 5 stars$1.17+2.8%N/A+365.9%$2.92M$9.29M-0.0660Earnings ReportDKDCAData Knights AcquisitionN/A$0.41-6.9%N/A-12.6%$2.12MN/A-2.162High Trading VolumeIQVIQVIA4.9341 of 5 stars$156.09+4.8%$231.71+48.4%-40.1%$27.00B$15.50B20.8186,000Positive NewsAnalyst ForecastHigh Trading VolumeINCYIncyte4.8758 of 5 stars$60.85+3.2%$73.53+20.8%+12.9%$11.78B$4.41B225.382,320Positive NewsICLRICON Public4.4139 of 5 stars$140.22+4.7%$215.33+53.6%-60.2%$11.32B$8.19B14.7141,100 Related Companies and Tools Related Companies Inotiv Competitors AIkido Pharma Competitors Luna Innovations Competitors OneMedNet Competitors bioAffinity Technologies Competitors iSpecimen Competitors Data Knights Acquisition Competitors IQVIA Competitors Incyte Competitors ICON Public Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BASI) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredDollar Collapse Warning: Protect Your Wealth NOWGlobal central banks are stockpiling gold. Billionaires are hedging with precious metals. And thousands of Ame...Lear Capital | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredTrump + Musk = AI’s turning pointTrump may not code… but he knows how to pick winners. And according to insiders, his administration is prep...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bioanalytical Systems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bioanalytical Systems With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
